Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 50.26%201.1M | ---- | 2.03%260.7M | ---- | -18.18%133.83M | ---- | 31.47%255.52M | ---- | 24.93%163.57M |
| Profit adjustment | ||||||||||
| Investment loss (gain) | ---- | -28.58%-3.9M | ---- | 85.02%-9.5M | ---- | 91.97%-3.04M | ---- | -38.83%-63.37M | ---- | -7.56%-37.82M |
| Impairment and provisions: | ---- | -88.27%1.59M | ---- | 249.78%21.47M | ---- | 383.20%13.52M | ---- | -177.06%-14.33M | ---- | -137.63%-4.77M |
| -Other impairments and provisions | ---- | -88.56%1.52M | ---- | 239.47%19.83M | ---- | 385.80%13.33M | ---- | -245.13%-14.22M | ---- | -244.28%-4.66M |
| Revaluation surplus: | ---- | ---- | ---- | -76.03%10.06M | ---- | -36.44%10.99M | ---- | 77.51%41.95M | ---- | -53.18%17.28M |
| Asset sale loss (gain): | ---- | ---- | ---- | 1,635.80%172.08K | ---- | --353.83K | ---- | -336.24%-11.2K | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | 1,635.80%172.08K | ---- | --353.83K | ---- | -336.24%-11.2K | ---- | ---- |
| Depreciation and amortization: | ---- | 19.02%21.64M | ---- | 14.40%38.36M | ---- | 11.81%18.18M | ---- | 4.60%33.53M | ---- | 0.59%16.26M |
| -Amortization of intangible assets | ---- | 16.25%1.57M | ---- | 4.33%2.82M | ---- | 2.06%1.35M | ---- | -14.33%2.71M | ---- | -7.70%1.32M |
| Financial expense | ---- | 79.86%-1.16M | ---- | 87.66%-1.28M | ---- | 46.68%-5.76M | ---- | 55.92%-10.37M | ---- | 27.20%-10.81M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 92.40%611.66M | ---- | 25.88%-259.43M | ---- | 11.85%317.92M | ---- | -511.16%-350M | ---- | -12.95%284.24M |
| Accounts receivable (increase)decrease | ---- | 81.44%-29.87M | ---- | -335.50%-236.79M | ---- | -909.18%-160.9M | ---- | 402.61%100.55M | ---- | 124.31%19.88M |
| Accounts payable increase (decrease) | ---- | -81.66%-9.44M | ---- | 386.50%66.91M | ---- | 70.96%-5.2M | ---- | -121.13%-23.36M | ---- | -143.48%-17.9M |
| Special items of business | ---- | 61.41%13.37K | ---- | 184.52%121.01K | ---- | 155.50%8.28K | ---- | 272.71%42.53K | ---- | 341.11%3.24K |
| Adjustment items of business operations | 211.27%841.26M | 147.46%791.62M | 121.90%366.72M | -265.71%-109.33M | -32.15%270.27M | -25.59%319.9M | -19.46%165.27M | -112.41%-29.89M | -19.12%398.36M | -0.62%429.93M |
| Net cash from operations | 211.27%841.26M | 147.46%791.63M | 121.90%366.72M | -265.82%-109.2M | -32.15%270.27M | -25.59%319.91M | -19.46%165.27M | -112.40%-29.85M | -19.12%398.36M | -0.61%429.94M |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | -7.11%7.1M | -1.41%4.94M | 2.26%2.09M | -74.89%14.26M | -85.18%7.64M | -86.25%5.01M | -91.95%2.04M | 24.48%56.79M | 15.05%51.53M | 3.55%36.41M |
| Sale of fixed assets | -99.93%3.04K | ---- | ---- | 13,475.67%4.72M | --4.15M | --5.21M | -70.01%5.08K | -17.40%34.8K | ---- | ---- |
| Purchase of fixed assets | 56.52%-46.22M | -12.08%-33.08M | 24.67%-4.9M | -22.24%-162.35M | -119.51%-106.29M | -53.77%-29.52M | -776.41%-6.5M | -139.56%-132.82M | 29.04%-48.42M | 55.08%-19.2M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 251.78%39.34M | --26.65M | --26.65M |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---59.91M | ---59.91M |
| Recovery of cash from investments | -35.27%1.75B | -32.18%1.1B | -41.42%386M | -38.13%3.39B | -37.15%2.7B | -51.63%1.62B | -61.34%658.97M | 10.28%5.48B | 33.31%4.3B | 108.81%3.34B |
| Cash on investment | 26.17%-1.93B | 50.17%-1.06B | 68.77%-376M | 33.66%-3.3B | 43.49%-2.61B | 42.37%-2.12B | 36.22%-1.2B | 5.33%-4.97B | -24.97%-4.63B | -97.23%-3.68B |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 210.83%103.83M | 2,749.05%103.78M | 62.86%3.34M |
| Net cash from investment operations | -2,680.75%-221.02M | 102.27%11.86M | 101.31%7.2M | -109.20%-52.64M | 96.88%-7.95M | -49.64%-522.71M | -316.08%-549.37M | 251.59%572.42M | 48.63%-254.85M | -30.13%-349.31M |
| Net cash before financing | 136.44%620.24M | 496.19%803.49M | 197.35%373.92M | -129.83%-161.84M | 82.79%262.32M | -351.54%-202.8M | -624.96%-384.11M | 496.48%542.57M | 4,133.08%143.51M | -50.89%80.62M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -62.50%30M | -25.00%30M | --30M |
| Refund | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -220.00%-160M | ---130M | ---130M |
| Dividends paid - financing | 20.87%-60.75M | ---- | ---- | -107.22%-76.78M | -108.04%-76.78M | -8,514.57%-76.78M | ---- | -92.90%-37.05M | -94.41%-36.91M | 8.42%-891.28K |
| Other items of the financing business | -186.55%-111.02M | -193.11%-79.65M | ---- | -13.84%-67.78M | -63.20%-38.74M | ---27.17M | ---- | -35.58%-59.54M | 74.37%-23.74M | ---- |
| Net cash from financing operations | -48.69%-171.78M | 23.38%-79.65M | ---- | 36.20%-144.56M | 28.09%-115.52M | -3.04%-103.95M | ---- | -584.09%-226.59M | -124.35%-160.65M | -124.76%-100.89M |
| Effect of rate | -284.84%-1.66M | -130.96%-1.18M | -100.15%-3.51K | -134.19%-1.32M | -31.74%900.27K | 191.64%3.81M | 172.70%2.34M | -80.45%3.85M | -92.84%1.32M | -91.34%1.31M |
| Net Cash | 205.50%448.46M | 335.96%723.84M | 197.35%373.92M | -196.97%-306.4M | 956.62%146.8M | -1,413.56%-306.76M | -832.58%-384.11M | 285.90%315.98M | 77.20%-17.14M | -116.99%-20.27M |
| Begining period cash | -56.55%236.45M | -56.55%236.45M | -56.55%236.45M | 142.56%544.17M | 142.56%544.17M | 142.56%544.17M | 142.56%544.17M | -40.11%224.34M | -40.11%224.34M | -40.11%224.34M |
| Cash at the end | -1.25%683.25M | 297.60%959.11M | 275.82%610.37M | -56.55%236.45M | 231.79%691.87M | 17.45%241.23M | -40.63%162.41M | 142.56%544.17M | -34.40%208.52M | -59.65%205.38M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.